Reactive oxygen species and the central nervous system in salt-sensitive hypertension: Possible relationship with obesity-induced hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 39, Issue 1, 2012, Pages 111-116

  Ando, Katsuyuki ^a   Fujita, Megumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Central nervous system; Obesity; Rat models of hypertension; Reactive oxygen species; Sodium balance

Indexed keywords

ANGIOTENSIN II; APOCYNIN; BUTHIONINE SULFOXIMINE; CATECHOLAMINE; DEOXYCORTICOSTERONE ACETATE; DIPHENYLIODONIUM SALT; GLUTATHIONE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE DISMUTASE; TEMPOL;

ADRENERGIC STIMULATION; ADRENERGIC SYSTEM; ARTICLE; BORDERLINE HYPERTENSION; CATECHOLAMINE BLOOD LEVEL; DAHL SALT SENSITIVE RAT; ESSENTIAL HYPERTENSION; GANGLION BLOCK; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY PLASMA FLOW; KIDNEY TUBULE ABSORPTION; KIDNEY VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; NERVE CONDUCTION; NONHUMAN; OBESITY; OBESITY INDUCED HYPERTENSION; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT LOADING; SALT SENSITIVE HYPERTENSION; SODIUM RETENTION; SPLANCHNIC BLOOD FLOW; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; UPREGULATION; VASOCONSTRICTION; WEIGHT REDUCTION; WISTAR KYOTO RAT;

ADRENERGIC FIBERS; ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM; HUMANS; HYPERTENSION; KIDNEY; OBESITY; REACTIVE OXYGEN SPECIES; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 84855164626     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05510.x     Document Type: Article

References (69)

1. Eaton SB, Eaton SB III, Konner MJ, Shostak M. An evolutionary perspective enhances understanding of human nutritional requirements. J. Nutr. 1996; 126: 1732-40.
2. Ritz E, Mehls O. Salt restriction in kidney disease: A missed therapeutic opportunity? Pediatr. Nephrol. 2009; 24: 9-17.
3. Kawano Y, Ando K, Matsuura H, Tsuchihashi T, Fujita T, Ueshima H. Report of the Working Group for Dietary Salt Reduction of the Japanese Society of Hypertension: (1) Rationale of salt restriction target level for the management of hypertension. Hypertens. Res. 2007; 30: 879-86.
4. Matsui H, Shimosawa T, Uetake Y et al. Protective effect of potassium against the hypertensive cardiac dysfunction. Hypertension 2006; 48: 225-31.
5. Kido M, Ando K, Oba S, Fujita T. Renoprotective effect of pravastatin in salt-loaded Dahl salt-sensitive rats. Hypertens. Res. 2005; 28: 1009-15.
6. Kido M, Ando K, Onozato ML et al. Protective effect of dietary potassium against the vascular injury in salt-sensitive hypertension. Hypertension 2008; 51: 225-31.
7. Ogihara T, Asano T, Ando K et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 2002; 40: 83-9.
8. Fujita T, Henry WL, Bartter FC, Lake CR, Delea CS. Factors influencing blood pressure in salt-sensitive patients with hypertension. Am. J. Med. 1980; 69: 334-44.
9. Gill JR, Gullner HG, Lake CR, Lakatua DJ, Lan G. Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension 1988; 11: 312-19.
10. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int. 1982; 21: 371-8.
11. Yemane H, Busauskas M, Burris SK, Knuepfer MM. Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats. Exp. Physiol. 2010; 95: 51-5.
12. Sato Y, Ando K, Fujita T. Role of sympathetic nervous system in hypotensive action of taurine in DOCA-salt rats. Hypertension 1987; 9: 81-7.
13. Ando K, Ono A, Sato Y, Asano S, Fujita T. Involvement of the sympathetic nervous system in antihypertensive effect of cicletanine in salt-loaded young spontaneously hypertensive rats. Am. J. Hypertens. 1994; 7: 550-4.
14. Fujita T, Sato Y, Ando K. Changes in cardiac and hypothalamic noradrenergic activity with taurine in DOCA-salt rats. Am. J. Physiol. 1986; 251: H926-33.
15. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 2007; 50: 360-7.
16. Fujita T, Sato Y. Role of hypothalamic-renal noradrenergic systems in hypotensive action of potassium. Hypertension 1992; 20: 466-72.
17. Sato Y, Ando K, Ogata E, Fujita T. High potassium intake attenuates antinatriuretic response to air stress in DOCA-salt rats. Am. J. Physiol. 1991; 260: R941-5.
18. Weinstock M, Gorodetsky E, Kalman R. Renal denervation prevents sodium retention and hypertension in salt-sensitive rabbits with genetic baroreflex impairment. Clin. Sci. 1996; 90: 287-93.
19. Krum H, Schlaich M, Whitbourn R et al. Catheter-based renal sympathetic denervation for resistant hypertension: A multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-81.
20. DiBona GF. Neural regulation of renal tubular sodium reabsorption and renin secretion. Fed. Proc. 1985; 44: 2816-22.
21. Gang LC. Actions of adrenergic and cholinergic drugs on renal tubular cells. Pharmacol. Rev. 1992; 44: 81-102.
22. Dargie H. Sympathetic activity and regional blood flow in heart failure. Eur. Heart J. 1990; 11 (Suppl. A): 39-43.
23. Johnson MD, Malvin RL. Stimulation of renal sodium reabsorption by angiotensin II. Am. J. Physiol. 1977; 232: F298-306.
24. Green HD, Kepchar JH. Control of peripheral resistance in major systemic vascular beds. Physiol. Rev. 1959; 39: 617-86.
25. Folkow B, DiBona GF, Hjemdahl P, Thoren PH, Wallin BG. Measurement of plasma norepinephrine concentrations in human primary hypertension: A word of caution on their applicability for assessing neurogenic contributions. Hypertension 1983; 5: 399-403.
26. Ando K, Fujita T. Abnormal renal hemodynamics in salt-sensitive patients with essential hypertension. Jpn. Circ. J. 1985; 49: 984-9.
27. Fujita T, Ando K, Ogata E. Systemic and regional hemodynamics in patients with salt-sensitive hypertension. Hypertension 1990; 16: 235-44.
28. Lawton WJ, Sinkey CA, Fitz AE, Mark AL. Dietary salt produces abnormal renal vasoconstrictor responses to upright posture in borderline hypertensive subjects. Hypertension 1988; 11: 529-36.
29. Forsyth RP. Regional blood-flow changes during 72-hour avoidance schedules in the monkey. Science 1971; 173: 546-54.
30. Brod J, Fencl V, Hejl Z, Jirka J. Circulatory changes underlying blood pressure elevation during acute emotional stress (mental arithmetic) in normotensive and hypertensive subjects. Clin. Sci. 1959; 18: 269-79.
31. Kanbar R, Chapuis B, Oréa V, Barrès C, Julien C. Baroreflex control of renal sympathetic nerve activity during air-jet stress in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007; 292: R362-7.
32. Schneider MP, Klingbeil AU, Schlaich MP, Langenfeld MR, Veelken R, Schmieder RE. Impaired sodium excretion during mental stress in mild essential hypertension. Hypertension 2001; 37: 923-7.
33. Ono A, Kuwaki T, Cao WH, Kumada M, Fujita T. High calcium diet prevents baroreflex impairment in salt-loaded spontaneously hypertensive rats. Hypertension 1994; 24: 83-90.
34. Ono A, Kuwaki T, Kumada M, Fujita T. Differential central modulation of the baroreflex by salt loading in normotensive and spontaneously hypertensive rats. Hypertension 1997; 29: 808-14.
35. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc. Natl Acad. Sci. USA 1991; 88: 10045-8.
36. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 1997; 95: 588-93.
37. - and systolic blood pressure in mice. Circ. Res. 2001; 89: 408-14.
38. Vaziri ND, Wang XQ, Oveisi F, Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 2000; 36: 142-6.
39. Xu H, Fink GD, Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am. J. Physiol. Heart Circ. Physiol. 2002; 283: H885-92.
40. Shokoji T, Nishiyama A, Fujisawa Y et al. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 2003; 41: 266-73.
41. Fujita M, Kuwaki T, Ando K, Fujita T. Sympatho-inhibitory action of endogenous adrenomedullin through inhibition of oxidative stress in the brain. Hypertension 2005; 45: 1165-72.
42. Lindley TE, Doobay MF, Sharma RV, Davisson RL. Superoxide is involved in the central nervous system activation and sympathoexcitation of myocardial infarction-induced heart failure. Circ. Res. 2004; 94: 402-9.
43. Zanzinger J, Czachurski J. Chronic oxidative stress in the RVLM modulates sympathetic control of circulation in pigs. Pflügers Arch. 2000; 439: 489-94.
44. Lob HE, Marvar PJ, Guzik TJ et al. Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Hypertension 2010; 55: 277-83.
45. Chen J, Gu D, Huang J et al. Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: A dietary intervention study. Lancet 2009; 373: 829-35.
46. Rocchini AP, Key J, Bondie D et al. The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N. Engl. J. Med. 1989; 32: 580-5.
47. Masuo K, Mikami H, Itoh M, Ogihara T, Tuck ML. Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens. Res. 2000; 23: 303-10.
48. Grassi G, Seravalle G, Dell'Oro R et al. Participation of the hypothalamus-hypophysis axis in the sympathetic activation of human obesity. Hypertension 2001; 38: 1316-20.
49. Alvarez GE, Beske SD, Ballard TP, Davy KP. Sympathetic neural activation in visceral obesity. Circulation 2002; 106: 2533-6.
50. Morgan DA, Anderson EA, Mark AL. Renal sympathetic nerve activity is increased in obese Zucker rats. Hypertension 1995; 25: 834-8.
51. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25: 893-7.
52. Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation 2009; 119: 978-86.
53. Ohmori K, Ebihara S, Kuriyama S et al. The relationship between body mass index and a plasma lipid peroxidation biomarker in an older, healthy Asian community. Ann. Epidemiol. 2005; 15: 80-4.
54. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int. J. Obes. 2006; 30: 400-18.
55. Smith AD, Brands MW, Wang MH, Dorrance AM. Obesity-induced hypertension develops in young rats independently of the renin-angiotensin-aldosterone system. Exp. Biol. Med. 2006; 231: 282-7.
56. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND. Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism 2006; 55: 928-34.
57. Chinen I, Shimabukuro M, Yamakawa K et al. Vascular lipotoxicity: Endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats. Endocrinology 2007; 148: 160-5.
58. Engeli S, Böhnke J, Gorzelniak K et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005; 45: 356-62.
59. Franco M, Sanchez-Lozada LG, Bautista R, Johnson RJ, Rodriguez-Iturbe B. Pathophysiology of salt-sensitive hypertension: A new scope of an old problem. Blood Purif. 2008; 26: 45-8.
60. Sun C, Zubeevic J, Polson JW et al. Shift to an involvement of phosphatidylinositol 3-kinase in angiotensin II actions on nucleus solitarii neurons of the spontaneously hypertensive rats. Circ. Res. 2009; 105: 1248-55.
61. de Wardener HE. The hypothalamus and hypertension. Physiol. Rev. 2001; 81: 1599-658.
62. de Kloet AD, Krause EG, Woods SC. The renin angiotensin system and the metabolic syndrome. Physiol. Behav. 2010; 100: 525-34.
63. Zimmerman MC, Lazartigues E, Lang JA et al. Superoxide mediates the action of angiotensin II in the central nervous system. Circ. Res. 2002; 91: 1038-45.
64. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2005; 46: 533-9.
65. Zhao X, White R, Huang BS, Van Huysse J, Leenen FH. High salt intake and the brain renin-angiotensin system in Dahl salt-sensitive rats. J. Hypertens. 2001; 19: 89-98.
66. Swenson SJ, Speth RC, Porter JP. Effect of a perinatal high-salt diet on blood pressure control mechanisms in young Sprague-Dawley rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004; 286: R764-70.
67. Huang BS, White RA, Jeng AY, Leenen FH. Role of central nervous system aldosterone synthase and mineralocorticoid receptors in salt-induced hypertension in Dahl salt-sensitive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009; 296: R994-1000.
68. Fujita T. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 2010; 55: 813-18.
69. Kimura Y, Hirooka Y, Sagara Y et al. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ. Res. 2005; 96: 252-60.